Statistics for BriaCell Therapeutics Corp. (id:13686 BCT)
Valuation metrics
Market cap
59.70M
Enterprise value
38.02M
Trailing P/E (ttm)
Forward P/E
-2.83
PEG ratio
-2.83
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA
3.00
Overview
Shares outstanding
36.18M
Float
14.64M
Shares short
9.21K
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
83.09K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
8.00
52-Week change
-821.05%
Beta
1.82
50-Day moving average
1.17
200-Day moving average
1.89
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
January 2, 2020
Ex-dividend date
October 5, 2017
Last split factor
2:1
Last split date
September 5, 2023
Financials
Fiscal yearFiscal year ends
July 31, 2024
Most recent quarter (mrq)
July 31, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-126.11%
Return on equity
178.46%
Income statement
Revenue (ttm)
Revenue per share (ttm)
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-47,144,745.00
Net income to common (ttm)
-6,794,538.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.22M
Total cash per share (mrq)
5.00
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
49.00%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-34,212,055.00
Levered free cash flow (LFCF)
-15,364,251.00